DrugPatentWatch Database Preview
PROCARDIA Drug Profile
see a sample report or, see our see our flat-rate plans
When do Procardia patents expire, and when can generic versions of Procardia launch?
The generic ingredient in PROCARDIA is nifedipine. There are thirty-nine drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the nifedipine profile page.
Summary for PROCARDIA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 104 |
| Clinical Trials: | 5 |
| Patent Applications: | 4,381 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PROCARDIA at DailyMed |
Pharmacology for PROCARDIA
| Ingredient-type | Dihydropyridines |
| Drug Class | Dihydropyridine Calcium Channel Blocker |
| Mechanism of Action | Calcium Channel Antagonists |
Medical Subject Heading (MeSH) Categories for PROCARDIA
Synonyms for PROCARDIA
| 1,?4-?DIHYDRO-?2,?6-?DIMETHYL-?4-?(2-?NITROPHENYL)-?3,?5-?DIMETHYL ESTER-?3,?5-?PYRIDINEDICARBOXYLIC ACID |
| 1,4-Dihydro-2,6-dimethyl-4-(2- nitrophenyl)-3,5-pyridine- dicarboxylic acid dimethyl ester |
| 1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine-dicarboxylic acid dimethyl ester |
| 1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester |
| 101539-70-2 |
| 101554-38-5 |
| 2,6-Dimethyl-3,5-dicarbomethoxy-4-(2-nitrophenyl)-1,4-dihydropyridine |
| 2,6-dimethyl-4-(2nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3,5-dimethyl ester |
| 21829-25-4 |
| 29N254 |
| 3,5-dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
| 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, dimethyl ester |
| 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, dimethyl ester (9CI) |
| 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-, dimethyl ester (8CI) |
| 4-(2-Nitrophenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine |
| 4-(2'-nitrophenyl)-2,6 dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridine |
| 4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester |
| 4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester [German] |
| 4-(2'-nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridine |
| 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine |
| 5-22-04-00268 (Beilstein Handbook Reference) |
| 60299-11-8 (mono-hydrochloride) |
| AB00052051_06 |
| AB00052051_07 |
| AB00052051-05 |
| AB0012099 |
| AB1009450 |
| AC-8061 |
| AC1L1I9V |
| AC1Q4254 |
| ACT02669 |
| Adalat |
| Adalat (TN) |
| Adalat 10 |
| Adalat 20 |
| Adalat 5 |
| Adalat CC |
| Adalat CR |
| Adalat Crono |
| Adalat FT |
| Adalat GITS |
| Adalat GITS 30 |
| Adalat LA |
| Adalat LP |
| Adalat Oros |
| Adalat PA |
| Adalat Retard |
| Adalat XL |
| Adalat, Procardia |
| Adalate |
| Adalate LP |
| Adapine |
| Adapress |
| Adcock Ingram Brand of Nifedipine |
| Adipine XL |
| Afeditab |
| Afeditab CR |
| Afeditab CR (TN) |
| AJ-126377 |
| AK128399 |
| AK230134 |
| AKOS002942507 |
| Alat |
| Aldipin |
| Aldipine |
| Alfadal |
| Alonix |
| Alonix S |
| Alpha-Nifedipine Retard |
| AN-8351 |
| Angipec |
| Anifed |
| Anpine |
| ANW-42547 |
| Apo-Nifed |
| Aprical |
| Aprical long |
| ARONIS24171 |
| AWD Pharma Brand of Nifedipine |
| BAY 1040 |
| BAY A 1040 |
| BAY A1040 |
| Bay-1040 |
| BAY-a 1040 |
| Bay-a-1040 |
| Bay1040 |
| BAYa1040 |
| Bayer Brand of Nifedipine |
| BBL023163 |
| BCBcMAP01_000046 |
| BDBM50000778 |
| BDBM50101817 |
| BIDD:GT0442 |
| BIDD:PXR0034 |
| BIM-0050796.0001 |
| Bio-0733 |
| Bio1_000112 |
| Bio1_000601 |
| Bio1_001090 |
| Bio2_000111 |
| Bio2_000591 |
| Bonacid |
| BPBio1_000271 |
| BRD-K96354014-001-01-3 |
| BRN 0497773 |
| BSPBio_000245 |
| BSPBio_001391 |
| BSPBio_002071 |
| C07266 |
| C17H18N2O6 |
| Calcibloc |
| Calcigard |
| Calcilat |
| Camont |
| Cardifen |
| Cardilat |
| Cardionorm |
| CAS-21829-25-4 |
| CBiol_001826 |
| CCG-100758 |
| CCG-40115 |
| CCRIS 6074 |
| CHEBI:7565 |
| CHEMBL193 |
| Chronadalate |
| Chronadalate LP |
| cid_4485 |
| Citilat |
| CJ-22221 |
| cMAP_000042 |
| Coracten |
| Coracten XL |
| Coral |
| Cordafen |
| Cordaflex |
| Cordalat |
| Cordicant |
| Cordilan |
| Cordipin |
| Cordipine |
| Corinfar |
| Corotrend |
| Corynphar |
| CPD000058291 |
| CPD004727070 |
| CS-2296 |
| CTK1A2296 |
| D00437 |
| D04OSE |
| DB01115 |
| Depin |
| Dignokonstant |
| Dilafed |
| Dilcor |
| Dimethyl (4-(2-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate) |
| Dimethyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate |
| Dimethyl 1,4-dihydro-2,6-dimethyl-4-(2'-nitrophenyl)-3,5-pyridinedicarboxylate |
| Dimethyl 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarboxylate |
| Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate |
| Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate # |
| dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
| Dimethyl 4-(2-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate |
| Dipinkor |
| DivK1c_000313 |
| DR001734 |
| DSSTox_CID_5715 |
| DSSTox_GSID_25715 |
| DSSTox_RID_77889 |
| DTXSID2025715 |
| Duranifin |
| Ecodipi |
| Ecodipin |
| Ecodipin E |
| EINECS 244-598-3 |
| Emaberin |
| EU-0100819 |
| F2173-0802 |
| Fedcor |
| Fedcor Retard |
| fedipin |
| Fenamon |
| Fenamon SR |
| Fenigidin |
| Fenihidin |
| Fenihidine |
| Fortipine LA |
| FT-0630478 |
| FT-0653833 |
| Glopir |
| GTPL2514 |
| Hadipin |
| HE193436 |
| HE325709 |
| Hexadilat |
| HMS1361F13 |
| HMS1568M07 |
| HMS1791F13 |
| HMS1920P19 |
| HMS1989F13 |
| HMS2051O03 |
| HMS2089H11 |
| HMS2091H20 |
| HMS2095M07 |
| HMS2233B22 |
| HMS3262D19 |
| HMS3267G06 |
| HMS3393O03 |
| HMS3651M19 |
| HMS500P15 |
| HSDB 7775 |
| HY-B0284 |
| HYIMSNHJOBLJNT-UHFFFAOYSA-N |
| I06-0051 |
| I06-1286 |
| I9ZF7L6G2L |
| IDI1_000313 |
| IDI1_033861 |
| Infedipin |
| Introcar |
| K-6191 |
| KB-1712P |
| KBio1_000313 |
| KBio2_000111 |
| KBio2_001459 |
| KBio2_002400 |
| KBio2_002679 |
| KBio2_004027 |
| KBio2_004968 |
| KBio2_005247 |
| KBio2_006595 |
| KBio2_007536 |
| KBio3_000221 |
| KBio3_000222 |
| KBio3_001571 |
| KBio3_002879 |
| KBioGR_000111 |
| KBioGR_000627 |
| KBioGR_002400 |
| KBioSS_000111 |
| KBioSS_001459 |
| KBioSS_002405 |
| Kordafen |
| Korinfar |
| KRKA Brand of Nifedipine |
| KS-00000WTS |
| KS-000046XF |
| KS-1456 |
| KSC202E9N |
| L001054 |
| Lopac-N-7634 |
| Lopac0_000819 |
| LP00819 |
| Macorel |
| MCULE-7336870265 |
| Megalat |
| methyl 5-(methoxycarbonyl)-2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine- 3-carboxylate |
| MFCD00057326 |
| MLS000028521 |
| MLS000758222 |
| MLS001148146 |
| MLS001401371 |
| MolPort-000-787-707 |
| Monohydrochloride, Nifedipine |
| Myogard |
| N 7634 |
| N0528 |
| N1fedilat |
| NC00008 |
| NCGC00015748-01 |
| NCGC00015748-02 |
| NCGC00015748-03 |
| NCGC00015748-04 |
| NCGC00015748-05 |
| NCGC00015748-06 |
| NCGC00015748-07 |
| NCGC00015748-08 |
| NCGC00015748-09 |
| NCGC00015748-10 |
| NCGC00015748-11 |
| NCGC00015748-12 |
| NCGC00015748-13 |
| NCGC00015748-14 |
| NCGC00015748-15 |
| NCGC00015748-17 |
| NCGC00021710-02 |
| NCGC00024983-01 |
| NCGC00024983-02 |
| NCGC00024983-03 |
| NCGC00024983-04 |
| NCGC00024983-05 |
| NCGC00024983-06 |
| NCGC00024983-07 |
| NCGC00024983-08 |
| NCGC00091707-01 |
| NCGC00091707-02 |
| NCGC00091707-03 |
| NCGC00257858-01 |
| NCGC00261504-01 |
| Nedipin |
| Nicardia |
| Nifangin |
| Nifar |
| Nifdemin |
| Nifebene |
| Nifecard |
| Nifecor |
| Nifedepat |
| Nifediac |
| Nifedical |
| Nifedical (TN) |
| Nifedical XL |
| Nifedicor |
| Nifedin |
| Nifedine |
| nifedipin |
| nifedipine |
| Nifedipine (Adalat) |
| Nifedipine (JP15/USP/INN) |
| Nifedipine (JP17/USP/INN) |
| Nifedipine [USAN:BAN:INN:JAN] |
| Nifedipine [USAN:USP:INN:BAN:JAN] |
| Nifedipine Bayer Brand |
| Nifedipine GTIS |
| Nifedipine KRKA Brand |
| Nifedipine Monohydrochloride |
| Nifedipine Orion Brand |
| Nifedipine Pfizer Brand |
| Nifedipine Retard |
| Nifedipine-GTIS |
| Nifedipine, >=98% (HPLC), powder |
| Nifedipine, 98% 5g |
| Nifedipine, British Pharmacopoeia (BP) Reference Standard |
| Nifedipine, European Pharmacopoeia (EP) Reference Standard |
| Nifedipine, pharmaceutical secondary standard; traceable to USP, PhEur and BP |
| Nifedipine, United States Pharmacopeia (USP) Reference Standard |
| Nifedipino |
| Nifedipino [INN-Spanish] |
| Nifedipinum |
| Nifedipinum [INN-Latin] |
| Nifedipres |
| Nifedirex LP |
| Nifelan |
| Nifelat |
| Nifelat Q |
| Nifelate |
| Nifensar XL |
| Nificard |
| Nifidine |
| Nifipen |
| NINDS_000313 |
| Niphedipine |
| NSC-757242 |
| NSC757242 |
| Opera_ID_1816 |
| Oprea1_788617 |
| Orion Brand of Nifedipine |
| Orix |
| Oxcord |
| Pfizer Brand of Nifedipine |
| Pharmakon1600-01500431 |
| Pidilat |
| Prestwick_357 |
| Prestwick0_000063 |
| Prestwick1_000063 |
| Prestwick2_000063 |
| Prestwick3_000063 |
| Procardia (TN) |
| Procardia XL |
| Q-201471 |
| RTC-063561 |
| s1808 |
| SAM001246963 |
| SBB012573 |
| SBI-0050796.P004 |
| SC-15173 |
| SCHEMBL3968 |
| Sepamit |
| Slofedipine XL |
| SMR000058291 |
| SPBio_001016 |
| SPBio_002166 |
| Spectrum_000979 |
| SPECTRUM1500431 |
| Spectrum2_001058 |
| Spectrum3_000516 |
| Spectrum4_000074 |
| Spectrum5_001278 |
| SR-01000075332 |
| SR-01000075332-1 |
| ST066898 |
| ST24048791 |
| STK735567 |
| SYN3028 |
| TC-063561 |
| Tensipine MR |
| Tibricol |
| Tocris-1075 |
| Tox21_110212 |
| Tox21_110212_1 |
| Tox21_200304 |
| Tox21_500819 |
| UNII-I9ZF7L6G2L |
| Vascard |
| Z90350374 |
| Zenusin |
| ZINC85205448 |
US Patents and Regulatory Information for PROCARDIA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | PROCARDIA | nifedipine | CAPSULE;ORAL | 018482-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Pfizer | PROCARDIA XL | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 019684-002 | Sep 6, 1989 | AB2 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Pfizer | PROCARDIA | nifedipine | CAPSULE;ORAL | 018482-002 | Jul 24, 1986 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Pfizer | PROCARDIA XL | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 019684-001 | Sep 6, 1989 | AB2 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
Expired US Patents for PROCARDIA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | PROCARDIA | nifedipine | CAPSULE;ORAL | 018482-002 | Jul 24, 1986 | ➤ Sign Up | ➤ Sign Up |
| Pfizer | PROCARDIA | nifedipine | CAPSULE;ORAL | 018482-001 | Approved Prior to Jan 1, 1982 | ➤ Sign Up | ➤ Sign Up |
| Pfizer | PROCARDIA | nifedipine | CAPSULE;ORAL | 018482-002 | Jul 24, 1986 | ➤ Sign Up | ➤ Sign Up |
| Pfizer | PROCARDIA | nifedipine | CAPSULE;ORAL | 018482-001 | Approved Prior to Jan 1, 1982 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
see a sample report or, see our see our flat-rate plans
